1. Home
  2. IGI vs NSPR Comparison

IGI vs NSPR Comparison

Compare IGI & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Investment Grade Defined Opportunity Trust Inc.

IGI

Western Asset Investment Grade Defined Opportunity Trust Inc.

N/A

Current Price

$16.49

Market Cap

98.8M

Sector

Finance

ML Signal

N/A

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.92

Market Cap

81.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IGI
NSPR
Founded
2009
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.8M
81.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IGI
NSPR
Price
$16.49
$1.92
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
33.9K
60.0K
Earning Date
01-01-0001
11-04-2025
Dividend Yield
4.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,779,000.00
Revenue This Year
N/A
$22.76
Revenue Next Year
N/A
$75.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.04
52 Week Low
$15.13
$1.59
52 Week High
$17.79
$3.80

Technical Indicators

Market Signals
Indicator
IGI
NSPR
Relative Strength Index (RSI) 49.91 48.73
Support Level $16.38 $1.66
Resistance Level $16.59 $2.15
Average True Range (ATR) 0.12 0.16
MACD 0.01 -0.01
Stochastic Oscillator 66.67 52.94

Price Performance

Historical Comparison
IGI
NSPR

About IGI Western Asset Investment Grade Defined Opportunity Trust Inc.

Western Asset Invstm Grd Dfnd Opp Tr Inc operates as a non-diversified closed-end management investment company. Its primary investment objective is to provide current income and then liquidate & distribute substantially all of the Fund's net assets to stockholders. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets in investment-grade corporate fixed-income securities of varying maturities.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: